Table 1.
Baseline Characteristics of Patients (N = 228)
| Age, yrs | 61.2 (18–91) |
| Sex | |
| Male | 159 (69.7) |
| Female | 69 (30.3) |
| Race | |
| Non-Hispanic white | 127 (55.7) |
| Hispanic | 37 (16.2) |
| African-American | 7 (3.1) |
| Asian | 34 (14.9) |
| Unknown or other | 23 (10.1) |
| Comorbid cardiovascular risk factors | |
| Pre-existing hypertension (by 2017 ACC/AHA criteria) | 183 (80.3) |
| Pre-existing hypertension (by 2014 JNC 8 criteria) | 144 (63.2) |
| Hyperlipidemia | 99 (43.4) |
| Diabetes | 57 (25.0) |
| Pre-existing congestive heart failure | 12 (5.3) |
| Baseline blood pressure (mm Hg) before first treatment | |
| Systolic | 130.2 ± 16.3 |
| Diastolic | 76.8 ± 9.3 |
| Baseline antihypertensive agents | |
| ACE inhibitor or ARBs | 61 (26.8) |
| Beta-blockers | 59 (25.9) |
| Calcium-channel blockers | 45 (19.7) |
| Other | 33 (14.5) |
| Baseline estimated glomerular filtration rate (ml/min/1.73 m2) before first treatment | 63.7 ± 21.2 |
Values are mean (range), n (%), or mean ± SD.
ACC/AHA = American College of Cardiology/American Heart Association; ACE = angiotensin-converting enzyme; ARB = angiotensin II receptor blocker; JNC = Joint National Committee.